Dahu Health Industry Co (SHSE:600257) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600257 Dahu Health Industry Co Ltd SHSE:600257
48 GF Score
Price ¥4.84
GF Value ¥4.47
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dahu Health Industry Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Dahu Health Industry Co Valuation Rank Related Terms

SHSE:600257
48GF Score
Dahu Health Industry Co Ltd SHSE:600257
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dahu Health Industry Co (SHSE:600257) Overvalued in 2026?

Based on GuruFocus' analysis, Dahu Health Industry Co stock appears to be overvalued. The current stock price of ¥4.84 is trading 8.3% above its estimated GF Value™ of ¥4.47. GuruFocus considers Dahu Health Industry Co to be Fairly Valued.

Key valuation signals for SHSE:600257:

  • Valuation Rank:
  • GF Value™: ¥4.47 vs. price of ¥4.84 (8.3% above fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600257 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dahu Health Industry Co Business Description

Address Jianmin Lane Community Construction East Road, No. 348, Danyang Street, Wuling District, Hunan Province, Changde, CHN, 415000
Dahu Health Industry Co Ltd engages in aquatic products and waterfowl breeding, processing, and comprehensive development, alongside foreign investment in proprietary Chinese medicine production and sales. Its operations include medical and food production and sales, nursing, hospital, elderly care, and health services. It also provides artificial intelligence-related technical consulting and system integration, and sells consumer robots.
48GF Score

Get the complete analysis for SHSE:600257

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.84
Price
¥4.47
GF Value